Markets › India › NSE › PARNAXLAB

Parnax Lab Limited

NSE:PARNAXLABHealth Technology

₹108.97−3.50%At closeAt close · Mon 19 Oct · ≈ AED 4.21 · Market cap $13.9M

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	11.9%	15.2%	14.7%	13.1%	16.5%	13.1%	−3.3 pts
Operating margin	5.5%	10.8%	10.0%	8.8%	10.6%	9.0%	−1.6 pts
Net margin	−0.4%	5.1%	5.1%	5.1%	6.1%	4.7%	−1.4 pts
EBITDA margin	11.3%	14.4%	13.8%	12.5%	14.5%	12.2%	−2.3 pts
Return on equity	−1.1%	17.1%	13.9%	13.4%	13.9%	12.4%	−1.5 pts
Return on assets	−0.3%	5.4%	5.9%	5.1%	6.1%	5.2%	−0.9 pts
Return on capital employed	9.6%	24.3%	20.3%	15.6%	17.2%	16.9%	−0.3 pts
Debt / equity	1.8×	1.4×	0.9×	1.1×	0.8×	0.9×	+4.0%
Debt / assets	55.4%	45.0%	37.7%	42.4%	36.6%	36.4%	−0.3 pts
Interest coverage	1.0×	3.4×	3.4×	3.1×	3.7×	3.9×	+6.0%
Current ratio	0.7×	0.9×	0.9×	0.9×	0.9×	0.9×	+8.6%
Quick ratio	0.5×	0.6×	0.6×	0.5×	0.5×	0.5×	+7.5%
Cash ratio	0.0×	0.1×	0.0×	0.0×	0.0×	0.0×	−52.6%
Asset turnover	0.8×	1.1×	1.2×	1.0×	1.0×	1.1×	+10.4%
Inventory turnover	7.3×	6.9×	6.6×	5.2×	5.8×	5.6×	−3.0%
Receivables turnover	4.6×	4.0×	5.6×	5.3×	5.8×	6.3×	+8.4%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—